Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
Identifieur interne : 000028 ( Main/Exploration ); précédent : 000027; suivant : 000029Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
Auteurs : Sergi Hernández [Oman] ; Carmen Mu Oz-Almagro [Espagne] ; Pilar Ciruela [Espagne] ; Núria Soldevila [Espagne] ; Conchita Izquierdo [Espagne] ; Maria Gemma Codina [Espagne] ; Alvaro Díaz [Espagne] ; Fernando Moraga-Llop [Espagne] ; Juan José García-García [Espagne] ; Ángela Domínguez [Espagne]Source :
- Journal of clinical microbiology [ 1098-660X ] ; 2019.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Couverture vaccinale (statistiques et données numériques), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (épidémiologie), Hospitalisation (MeSH), Humains (MeSH), Incidence (MeSH), Indice de gravité de la maladie (MeSH), Infections à pneumocoques (microbiologie), Infections à pneumocoques (prévention et contrôle), Infections à pneumocoques (épidémiologie), Mâle (MeSH), Nourrisson (MeSH), Pandémies (statistiques et données numériques), Streptococcus pneumoniae (génétique), Sérogroupe (MeSH), Vaccins antipneumococciques (administration et posologie), Études prospectives (MeSH).
- MESH :
- administration et posologie : Vaccins antipneumococciques.
- génétique : Streptococcus pneumoniae.
- microbiologie : Infections à pneumocoques.
- prévention et contrôle : Infections à pneumocoques.
- statistiques et données numériques : Couverture vaccinale, Pandémies.
- épidémiologie : Espagne, Grippe humaine, Infections à pneumocoques.
- Adolescent, Enfant, Enfant d'âge préscolaire, Femelle, Hospitalisation, Humains, Incidence, Indice de gravité de la maladie, Mâle, Nourrisson, Sérogroupe, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Child (MeSH), Child, Preschool (MeSH), Female (MeSH), Hospitalization (MeSH), Humans (MeSH), Incidence (MeSH), Infant (MeSH), Influenza, Human (epidemiology), Male (MeSH), Pandemics (statistics & numerical data), Pneumococcal Infections (epidemiology), Pneumococcal Infections (microbiology), Pneumococcal Infections (prevention & control), Pneumococcal Vaccines (administration & dosage), Prospective Studies (MeSH), Serogroup (MeSH), Severity of Illness Index (MeSH), Spain (epidemiology), Streptococcus pneumoniae (genetics), Vaccination Coverage (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Pneumococcal Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human, Pneumococcal Infections.
- genetics : Streptococcus pneumoniae.
- microbiology : Pneumococcal Infections.
- prevention & control : Pneumococcal Infections.
- statistics & numerical data : Pandemics, Vaccination Coverage.
- Adolescent, Child, Child, Preschool, Female, Hospitalization, Humans, Incidence, Infant, Male, Prospective Studies, Serogroup, Severity of Illness Index.
Abstract
The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of Streptococcus pneumoniae by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ2 test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55; P < 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47; P < 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77; P = 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29; P = 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.
DOI: 10.1128/JCM.00363-19
PubMed: 31189583
PubMed Central: PMC6663900
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</title>
<author><name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author><name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital de Nens, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital de Nens, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="4"><nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31189583</idno>
<idno type="pmid">31189583</idno>
<idno type="doi">10.1128/JCM.00363-19</idno>
<idno type="pmc">PMC6663900</idno>
<idno type="wicri:Area/Main/Corpus">00014</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00014</idno>
<idno type="wicri:Area/Main/Curation">000014</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000014</idno>
<idno type="wicri:Area/Main/Exploration">000014</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</title>
<author><name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author><name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<affiliation wicri:level="3"><nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital de Nens, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital de Nens, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author><name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="4"><nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of clinical microbiology</title>
<idno type="eISSN">1098-660X</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Pandemics (statistics & numerical data)</term>
<term>Pneumococcal Infections (epidemiology)</term>
<term>Pneumococcal Infections (microbiology)</term>
<term>Pneumococcal Infections (prevention & control)</term>
<term>Pneumococcal Vaccines (administration & dosage)</term>
<term>Prospective Studies (MeSH)</term>
<term>Serogroup (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Streptococcus pneumoniae (genetics)</term>
<term>Vaccination Coverage (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Couverture vaccinale (statistiques et données numériques)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à pneumocoques (microbiologie)</term>
<term>Infections à pneumocoques (prévention et contrôle)</term>
<term>Infections à pneumocoques (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Pandémies (statistiques et données numériques)</term>
<term>Streptococcus pneumoniae (génétique)</term>
<term>Sérogroupe (MeSH)</term>
<term>Vaccins antipneumococciques (administration et posologie)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term>
<term>Vaccination Coverage</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Couverture vaccinale</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
<term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Male</term>
<term>Prospective Studies</term>
<term>Serogroup</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Sérogroupe</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of <i>Streptococcus pneumoniae</i>
by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ<sup>2</sup>
test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55; <i>P</i>
< 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47; <i>P</i>
< 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77; <i>P</i>
= 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29; <i>P</i>
= 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31189583</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>57</Volume>
<Issue>8</Issue>
<PubDate><Year>2019</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Journal of clinical microbiology</Title>
<ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e00363-19</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00363-19</ELocationID>
<Abstract><AbstractText>The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of <i>Streptococcus pneumoniae</i>
by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ<sup>2</sup>
test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55; <i>P</i>
< 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47; <i>P</i>
< 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77; <i>P</i>
= 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29; <i>P</i>
= 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.</AbstractText>
<CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hernández</LastName>
<ForeName>Sergi</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-0461-6190</Identifier>
<AffiliationInfo><Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Muñoz-Almagro</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ciruela</LastName>
<ForeName>Pilar</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Soldevila</LastName>
<ForeName>Núria</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Izquierdo</LastName>
<ForeName>Conchita</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Codina</LastName>
<ForeName>Maria Gemma</ForeName>
<Initials>MG</Initials>
<AffiliationInfo><Affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Díaz</LastName>
<ForeName>Alvaro</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hospital de Nens, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moraga-Llop</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>García-García</LastName>
<ForeName>Juan José</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Domínguez</LastName>
<ForeName>Ángela</ForeName>
<Initials>Á</Initials>
<AffiliationInfo><Affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2019</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Clin Microbiol</MedlineTA>
<NlmUniqueID>7505564</NlmUniqueID>
<ISSNLinking>0095-1137</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C538862">13-valent pneumococcal vaccine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">13-valent pneumococcal conjugate vaccine</Keyword>
<Keyword MajorTopicYN="Y">highly invasive serotypes</Keyword>
<Keyword MajorTopicYN="Y">influenza virus</Keyword>
<Keyword MajorTopicYN="Y">invasive pneumococcal disease</Keyword>
<Keyword MajorTopicYN="Y">seasonality</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>03</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2019</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">31189583</ArticleId>
<ArticleId IdType="pii">JCM.00363-19</ArticleId>
<ArticleId IdType="doi">10.1128/JCM.00363-19</ArticleId>
<ArticleId IdType="pmc">PMC6663900</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Infect Dis. 2004 Oct 1;190(7):1203-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15346329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Feb;80(4):1629-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16439519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Sep 1;194(5):682-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16897668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2008 Aug;122(2):229-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18676537</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2008 Sep;14(9):828-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18844683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2009 Dec 31;4(12):e8540</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20046873</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2010 Oct;29(10):905-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20407400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2010 Oct 15;202(8):1287-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20822454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2012 Feb 1;205(3):458-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22158564</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2012 Feb;31(2):124-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22173137</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2012 Feb;18(2):208-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22306234</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2012 Jun;31(6):650-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22333697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2012 Nov;50(11):3451-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22875895</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2013 Apr;207(7):1135-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23303809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2013 Jun;66(6):512-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23473714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2013 May 21;13:229</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23687999</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2013 Oct 15;208(8):1274-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23901093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2014 Mar;43(3):833-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24036243</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2013 Dec 16;31(52):6232-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24176490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 Jan;58(2):188-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24190895</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2014 Jul;20(7):684-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24467648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2014 May;58(10):1369-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24621951</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2014 May;33(5):504-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24670957</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2014 Dec;20(12):O1088-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24977322</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):705-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25413925</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2015 Jan 06;12(1):e1001776</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25562317</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 May 1;60(9):1384-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25595749</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO Rep. 2015 Sep;16(9):1203-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26265006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Public Health. 2016 May 13;16:400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27178436</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2016 Aug 31;34(38):4565-4571</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27473304</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2016 Oct 4;11(10):e0163889</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27701435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2016 Dec 06;6:38532</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27922126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2017 Aug 14;12(8):e0183191</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28806737</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 1996 Jan;22(1):100-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8824973</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
<li>Oman</li>
</country>
<region><li>Catalogne</li>
<li>Communauté de Madrid</li>
</region>
<settlement><li>Barcelone</li>
<li>Madrid</li>
</settlement>
<orgName><li>Université de Barcelone</li>
</orgName>
</list>
<tree><country name="Oman"><region name="Catalogne"><name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
</region>
</country>
<country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
</region>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000028 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000028 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeEspagneV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:31189583 |texte= Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31189583" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeEspagneV1
This area was generated with Dilib version V0.6.37. |